Read Now: We're Bullish on 2 Non-Nifty Stocks
Here is the latest financial fact sheet of SUN PHARMA ADV. RES.. For more details, see the SUN PHARMA ADV. RES. quarterly results and SUN PHARMA ADV. RES. share price.
1 Day | % | 0.3 |
No. of shares | m | 324.52 |
1 Week | % | 5.0 |
1 Month | % | 6.8 |
1 Year | % | 119.2 |
52 week H/L | Rs | 423.6/163.2 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SUN PHARMA ADV. RES. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 438 | 211 | 210 | 349 | 306 | |
Low | Rs | 141 | 81 | 95 | 142 | 161 | |
Sales per share (Unadj.) | Rs | 7.0 | 2.9 | 9.7 | 5.0 | 7.4 | |
Earnings per share (Unadj.) | Rs | -5.5 | -11.9 | -5.8 | -7.5 | -6.9 | |
Diluted earnings per share | Rs | -4.5 | -9.6 | -4.7 | -6.3 | -6.9 | |
Cash flow per share (Unadj.) | Rs | -5.3 | -11.6 | -5.4 | -7.1 | -6.5 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 11.3 | -0.7 | -6.4 | -7.5 | 15.8 | |
Adj. book value per share | Rs | 9.1 | -0.6 | -5.2 | -6.3 | 15.8 | |
Shares outstanding (eoy) | m | 262.05 | 262.05 | 262.05 | 271.88 | 324.52 | |
Price / Sales ratio | x | 41.5 | 49.8 | 15.8 | 48.6 | 31.7 | |
Avg P/E ratio | x | -52.2 | -12.2 | -26.4 | -32.8 | -34.0 | |
P/CF ratio (eoy) | x | -55.0 | -12.6 | -28.4 | -34.6 | -35.9 | |
Price / Book Value ratio | x | 25.6 | -205.1 | -23.7 | -32.9 | 14.7 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 75,889 | 38,220 | 39,871 | 66,767 | 75,630 | |
Total wages/salary | Rs m | 811 | 931 | 916 | 983 | 1,070 |
SUN PHARMA ADV. RES. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 1,829 | 768 | 2,530 | 1,372 | 2,388 | |
Other income | Rs m | 135 | 98 | 54 | 68 | 109 | |
Total revenues | Rs m | 1,964 | 866 | 2,584 | 1,441 | 2,497 | |
Gross profit | Rs m | -1,513 | -3,100 | -1,350 | -1,867 | -2,141 | |
Depreciation | Rs m | 76 | 95 | 109 | 102 | 118 | |
Interest | Rs m | 1 | 27 | 107 | 133 | 76 | |
Profit before tax | Rs m | -1,454 | -3,124 | -1,511 | -2,034 | -2,226 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -1,454 | -3,124 | -1,511 | -2,034 | -2,226 | |
Gross profit margin | % | -82.7 | -403.6 | -53.4 | -136.1 | -89.6 | |
Effective tax rate | % | 0 | 0 | 0 | 0 | 0 | |
Net profit margin | % | -79.5 | -406.7 | -59.7 | -148.2 | -93.2 |
SUN PHARMA ADV. RES. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 2,574 | 672 | 598 | 712 | 4,550 | |
Current liabilities | Rs m | 950 | 2,354 | 2,334 | 1,714 | 1,789 | |
Net working cap to sales | % | 88.8 | -218.9 | -68.6 | -73.1 | 115.6 | |
Current ratio | x | 2.7 | 0.3 | 0.3 | 0.4 | 2.5 | |
Inventory Days | Days | 539 | 370 | 111 | 272 | 815 | |
Debtors Days | Days | 203 | 762 | 254 | 738 | 500 | |
Net fixed assets | Rs m | 1,411 | 2,054 | 1,666 | 2,089 | 3,752 | |
Share capital | Rs m | 262 | 262 | 262 | 272 | 325 | |
"Free" reserves | Rs m | 2,700 | -448 | -1,945 | -2,302 | 4,803 | |
Net worth | Rs m | 2,962 | -186 | -1,683 | -2,030 | 5,128 | |
Long term debt | Rs m | 11 | 64 | 1,125 | 0 | 0 | |
Total assets | Rs m | 3,985 | 2,726 | 2,297 | 2,801 | 8,301 | |
Interest coverage | x | -1,546.1 | -115.8 | -13.2 | -14.3 | -28.2 | |
Debt to equity ratio | x | 0 | -0.3 | -0.7 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.3 | 1.1 | 0.5 | 0.3 | |
Return on assets | % | -36.5 | -113.6 | -61.2 | -67.9 | -25.9 | |
Return on equity | % | -49.1 | 1,676.2 | 89.8 | 100.2 | -43.4 | |
Return on capital | % | -48.9 | 2,526.3 | 252.0 | 93.6 | -41.9 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 1,357 | 72 | 120 | 50 | 1,317 | |
Fx outflow | Rs m | 1,942 | 2,277 | 2,141 | 2,712 | 2,662 | |
Net fx | Rs m | -585 | -2,205 | -2,021 | -2,662 | -1,345 |
SUN PHARMA ADV. RES. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -1,719 | -2,108 | -1,519 | -2,082 | -691 | |
From Investments | Rs m | -1,022 | 1,553 | 16 | -292 | -5,483 | |
From Financial Activity | Rs m | 2,742 | 555 | 1,593 | 2,293 | 6,168 | |
Net Cashflow | Rs m | 1 | 0 | 90 | -81 | -6 |
Share Holding
Shareholding as on Dec 2023
|
Company Information
|
CHM: Dilip S Shanghvi | COMP SEC: Dinesh Lahoti | YEAR OF INC: 2006 | BSE CODE: 532872 | FV (Rs): 1 | DIV YIELD (%): - |
Read: SUN PHARMA ADV. RES. 2022-23 Annual Report Analysis
More Business Support Company Fact Sheets: ADANI PORTS & SEZ ZOMATO ADANI ENTERPRISES APOLLO HOSPITALS ADANI TOTAL GAS
Compare SUN PHARMA ADV. RES. With: ADANI PORTS & SEZ ZOMATO ADANI ENTERPRISES APOLLO HOSPITALS ADANI TOTAL GAS
After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.